MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
2020 · Targeted Oncology · 537 citations
https://doi.org/10.1007/s11523-020-00717-x
M
Massimiliano Salati
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
2.0K
Citations
22
h-index
43
i10-index
Massimiliano Salati is an academic researcher from Azienda Ospedaliero-Universitaria di Modena. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Cholangiocarcinoma and Gallbladder Cancer Studies & Colorectal Cancer Treatments and Studies. The author has an h-index of 22, co-authored 99 publications.
ORCID: 0000-0002-5579-7454Papers by this author
worksAssessing the impact of COVID-19 on liver cancer management (CERO-19)
2021 · JHEP Reports · 65 citations
https://doi.org/10.1016/j.jhepr.2021.100260
Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?
2017 · ESMO Open · 43 citations
https://doi.org/10.1136/esmoopen-2017-000206
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
2019 · European Journal of Cancer · 25 citations
https://doi.org/10.1016/j.ejca.2019.05.030
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation
2024 · Critical Reviews in Oncology/Hematology · 6 citations
https://doi.org/10.1016/j.critrevonc.2024.104607
Fighting HER2 in Gastric Cancer: Current Approaches and Future Landscapes
2025 · International Journal of Molecular Sciences · 4 citations
https://doi.org/10.3390/ijms26157285
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat